AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H2300-H2308, 2004. First published July 1, 2004; doi:10.1152/ajpheart.00065.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/H2300    most recent
00065.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baum, O.
Right arrow Articles by Zakrzewicz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baum, O.
Right arrow Articles by Zakrzewicz, A.

Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration

Oliver Baum,1,2 Luis Da Silva-Azevedo,2 Gregor Willerding,1 Achim Wöckel,1 Gerit Planitzer,1 Reinhart Gossrau,1 Axel R. Pries,2 and Andreas Zakrzewicz2

Departments of 1Anatomy and 2Physiology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, D-14195 Berlin-Dahlem, Germany

Submitted 26 January 2004 ; accepted in final form 23 June 2004

The increase of wall shear stress in capillaries by oral administration of the {alpha}1-adrenergic receptor antagonist prazosin induces angiogenesis in skeletal muscles. Because endothelial nitric oxide synthase (eNOS) is upregulated in response to elevated wall shear stress, we investigated the relevance of eNOS for prazosin-induced angiogenesis in skeletal muscles. Prazosin and/or the NOS inhibitor N{omega}-nitro-L-arginine methyl ester (L-NAME) were given to C57BL/6 wild-type mice and eNOS-knockout mice for 14 days. The capillary-to-fiber (C/F) ratio and capillary density (CD; no. of capillaries/mm2) were determined in frozen sections from extensor digitorum longus (EDL) muscles of these mice. Immunoblotting was performed to quantify eNOS expression in endothelial cells isolated from skeletal muscles, whereas VEGF (after precipitation with heparin-agarose) and neuronal NOS (nNOS) concentrations were determined in EDL solubilizates. In EDL muscles of C57BL/6 mice treated for 14 days, the C/F ratio was 28% higher after prazosin administration and 11% higher after prazosin and L-NAME feeding, whereas the CD increased by 21 and 13%, respectively. The C/F ratio was highest after day 4 of prazosin treatment and decreased gradually to almost constant values after day 8. Prazosin administration led to elevation of eNOS expression. VEGF levels were lowest at day 4, whereas nNOS values decreased after day 8. In EDL muscles of eNOS-knockout mice, no significant changes in C/F ratio, CD, or VEGF and nNOS expression were observed in response to prazosin administration. Our data suggest that the presence of eNOS is essential for prazosin-induced angiogenesis in skeletal muscle, albeit other signaling molecules might partially compensate for or contribute to this angiogenic activity. Furthermore, subsequent remodeling of the capillary system accompanied by sequential downregulation of VEGF and nNOS in skeletal muscle fibers characterizes shear stress-dependent angiogenesis.

angiogenesis; skeletal muscle; endothelial nitric oxide synthase



Address for reprint requests and other correspondence: O. Baum, Dept. of Anatomy and Physiology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Königin-Luise-Str. 15, D-14195 Berlin-Dahlem, Germany (E-mail: olibaum{at}zedat.fu-berlin.de)




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. V. Benest, O. A. Stone, W. H. Miller, C. P. Glover, J. B. Uney, A. H. Baker, S. J. Harper, and D. O. Bates
Arteriolar Genesis and Angiogenesis Induced by Endothelial Nitric Oxide Synthase Overexpression Results in a Mature Vasculature
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1462 - 1468.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Gassmann, A. Manini, T. Stallmach, B. Saam, G. Kuhn, B. Grenacher, A. Y. Bogdanova, and J. Vogel
Abortion in Mice with Excessive Erythrocytosis Is Due to Impaired Arteriogenesis of the Uterine Arcade
Biol Reprod, June 1, 2008; 78(6): 1049 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Hellsten, N. Rufener, J. J. Nielsen, B. Hoier, P. Krustrup, and J. Bangsbo
Passive leg movement enhances interstitial VEGF protein, endothelial cell proliferation, and eNOS mRNA content in human skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R975 - R982.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Hattori, S. Yamamoto, and N. Matsuda
Sympathetic Control of VEGF Angiogenic Signaling: Dual Regulations by {alpha}2-Adrenoceptor Activation?
Circ. Res., September 28, 2007; 101(7): 642 - 644.
[Full Text] [PDF]


Home page
J. Physiol.Home page
J. L. Williams, D. Cartland, A. Hussain, and S. Egginton
A differential role for nitric oxide in two forms of physiological angiogenesis in mouse
J. Physiol., February 1, 2006; 570(3): 445 - 454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.